Flora Growth (FLGC) Competitors $0.65 -0.02 (-2.92%) Closing price 04:00 PM EasternExtended Trading$0.66 +0.01 (+1.93%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends FLGC vs. ALXO, UNCY, APLT, OPTN, IPSC, ALGS, GANX, CTMX, HOWL, and ALVRShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include ALX Oncology (ALXO), Unicycive Therapeutics (UNCY), Applied Therapeutics (APLT), OptiNose (OPTN), Century Therapeutics (IPSC), Aligos Therapeutics (ALGS), Gain Therapeutics (GANX), CytomX Therapeutics (CTMX), Werewolf Therapeutics (HOWL), and AlloVir (ALVR). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. ALX Oncology Unicycive Therapeutics Applied Therapeutics OptiNose Century Therapeutics Aligos Therapeutics Gain Therapeutics CytomX Therapeutics Werewolf Therapeutics AlloVir Flora Growth (NASDAQ:FLGC) and ALX Oncology (NASDAQ:ALXO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Does the MarketBeat Community favor FLGC or ALXO? ALX Oncology received 40 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 64.71% of users gave ALX Oncology an outperform vote while only 60.00% of users gave Flora Growth an outperform vote. CompanyUnderperformOutperformFlora GrowthOutperform Votes1560.00% Underperform Votes1040.00% ALX OncologyOutperform Votes5564.71% Underperform Votes3035.29% Is FLGC or ALXO more profitable? ALX Oncology has a net margin of 0.00% compared to Flora Growth's net margin of -30.99%. ALX Oncology's return on equity of -93.02% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-30.99% -268.17% -57.51% ALX Oncology N/A -93.02%-70.67% Do analysts prefer FLGC or ALXO? Flora Growth currently has a consensus target price of $5.00, indicating a potential upside of 671.01%. ALX Oncology has a consensus target price of $4.14, indicating a potential upside of 397.96%. Given Flora Growth's higher probable upside, research analysts plainly believe Flora Growth is more favorable than ALX Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67ALX Oncology 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Does the media refer more to FLGC or ALXO? In the previous week, ALX Oncology had 13 more articles in the media than Flora Growth. MarketBeat recorded 16 mentions for ALX Oncology and 3 mentions for Flora Growth. Flora Growth's average media sentiment score of 0.64 beat ALX Oncology's score of 0.36 indicating that Flora Growth is being referred to more favorably in the media. Company Overall Sentiment Flora Growth Positive ALX Oncology Neutral Do institutionals and insiders hold more shares of FLGC or ALXO? 36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 98.0% of ALX Oncology shares are owned by institutional investors. 13.0% of Flora Growth shares are owned by insiders. Comparatively, 33.4% of ALX Oncology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings and valuation, FLGC or ALXO? Flora Growth has higher revenue and earnings than ALX Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$64.15M0.20-$57.04MN/AN/AALX OncologyN/AN/A-$160.80M-$2.60-0.32 Which has more volatility and risk, FLGC or ALXO? Flora Growth has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500. Comparatively, ALX Oncology has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. SummaryALX Oncology beats Flora Growth on 9 of the 15 factors compared between the two stocks. Remove Ads Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.60M$6.94B$5.63B$7.93BDividend YieldN/A2.72%4.89%4.05%P/E RatioN/A6.1223.6518.74Price / Sales0.20219.88371.05119.09Price / CashN/A65.6738.0534.64Price / Book0.836.616.854.19Net Income-$57.04M$139.99M$3.19B$247.07M7 Day Performance-7.36%-2.32%5.35%-2.82%1 Month Performance-22.97%-8.89%-1.03%-10.75%1 Year Performance-38.82%-4.99%12.50%0.56% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth3.1681 of 5 stars$0.65-2.9%$5.00+671.0%-37.0%$12.60M$64.15M0.00280Short Interest ↓ALXOALX Oncology4.0449 of 5 stars$1.03-6.4%$3.05+196.1%-92.2%$54.33MN/A-0.3540UNCYUnicycive Therapeutics2.9537 of 5 stars$0.52-5.4%$5.33+924.9%-58.8%$54.02M$680,000.00-0.549Short Interest ↑News CoveragePositive NewsGap DownAPLTApplied Therapeutics4.103 of 5 stars$0.46-9.8%$6.10+1,229.6%-91.3%$53.38M$-212,000.00-0.2830OPTNOptiNose4.1622 of 5 stars$5.27-9.3%$16.67+216.3%-80.8%$53.02M$75.67M-1.26190Upcoming EarningsNews CoveragePositive NewsIPSCCentury Therapeutics1.6349 of 5 stars$0.61-10.1%$10.00+1,528.9%-87.4%$52.20M$2.68M-0.33170News CoverageALGSAligos Therapeutics3.7973 of 5 stars$14.50-14.0%$75.00+417.2%-50.3%$52.03M$6.00M-1.0990Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGANXGain Therapeutics3.0545 of 5 stars$1.95-8.5%$7.25+271.8%-53.7%$51.72M$50,000.00-1.7720Short Interest ↓CTMXCytomX Therapeutics4.0504 of 5 stars$0.65-4.0%$5.77+787.7%-72.1%$50.89M$126.62M3.83170Earnings ReportAnalyst UpgradeGap DownHOWLWerewolf Therapeutics2.2286 of 5 stars$1.14-8.1%$9.33+718.7%-81.4%$50.80M$3.39M-0.7540Earnings ReportAnalyst ForecastNews CoverageALVRAlloVir2.2662 of 5 stars$10.02+2.2%N/A-43.2%$50.52MN/A-0.50110News CoverageGap Up Remove Ads Related Companies and Tools Related Companies ALXO Competitors UNCY Competitors APLT Competitors OPTN Competitors IPSC Competitors ALGS Competitors GANX Competitors CTMX Competitors HOWL Competitors ALVR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
